A detailed history of Monetta Financial Services Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Monetta Financial Services Inc holds 2,000 shares of VRTX stock, worth $900,740. This represents 0.79% of its overall portfolio holdings.

Number of Shares
2,000
Previous 2,000 -0.0%
Holding current value
$900,740
Previous $937,000 0.75%
% of portfolio
0.79%
Previous 0.81%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$407.69 - $446.08 $203,845 - $223,040
-500 Reduced 20.0%
2,000 $836,000
Q3 2022

Nov 09, 2022

SELL
$273.83 - $305.53 $410,745 - $458,294
-1,500 Reduced 37.5%
2,500 $724,000
Q4 2021

Feb 07, 2022

BUY
$177.01 - $223.45 $708,040 - $893,800
4,000 New
4,000 $878,000
Q2 2018

Aug 09, 2018

SELL
$145.72 - $169.96 $1.02 Million - $1.19 Million
-7,000 Closed
0 $0
Q1 2018

May 09, 2018

BUY
$151.6 - $177.13 $1.06 Million - $1.24 Million
7,000 New
7,000 $1.14 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Monetta Financial Services Inc Portfolio

Follow Monetta Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monetta Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Monetta Financial Services Inc with notifications on news.